What amount sold does ivWatch LLC report in Form D filings?

The latest linked filings report $89.3M sold across 8 identified offering(s). 1 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was ivWatch LLC's most recent SEC filing?

ivWatch LLC's most recent Form D filing was on 2024-09-19.

How many investors does ivWatch LLC have?

The most recent Form D filing lists 16 investor(s).

What type of securities does ivWatch LLC offer?

ivWatch LLC's SEC Form D filings indicate debt offerings.

ivWatch LLC

CIK: 0001511754·Other Health Care·NEWPORT NEWS, VA·Limited Liability Company

Reported Sold

$89,256,021

Total Filings

Identified Offerings

Last Filed

Sep 19, 2024

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 1 unlinked amendment excluded.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Sep 19, 2024Form D/A — Amendment

Reported sold: $26,933,659 · Target: $33,283,659

Rule 506(b)·16 investors

Changed: Reported amount sold, Offering target

Jun 14, 2024Form D/A — Amendment

Reported sold: $22,958,659 · Target: $27,283,659

Rule 506(b)·16 investors

Changed: Reported amount sold, Offering target, Reported investors

Jan 26, 2024Form D — New notice

Reported sold: $14,390,468 · Target: $20,240,468

Rule 506(b)·6 investors

Jan 9, 2024Form D/A — Amendment

Reported sold: $17,452,641 · Target: $17,452,641

No verified predecessor available.

Rule 506(b)·21 investors

May 4, 2023Form D — New notice

Reported sold: $10,692,961 · Target: $14,500,000

Rule 506(b)·9 investors

Feb 10, 2022Form D/A — Amendment

Reported sold: $13,709,845 · Target: $20,000,000

Rule 506(b)·15 investors

Changed: Reported amount sold, Offering target, Reported investors

Nov 1, 2021Form D/A — Amendment

Reported sold: $10,476,535 · Target: $13,000,000

Rule 506(b)·14 investors

Changed: Reported amount sold, Reported investors

Jul 7, 2020Form D — New notice

Reported sold: $1,500,000 · Target: $13,000,000

Rule 506(b)·2 investors

Jan 3, 2020Form D/A — Amendment

Reported sold: $18,918,445 · Target: $21,000,000

Rule 506(b)·51 investors

Changed: Reported amount sold, Offering target, Reported investors

Mar 14, 2019Form D/A — Amendment

Reported sold: $12,368,445 · Target: $16,000,000

Rule 506(b)·47 investors

Changed: Reported amount sold, Offering target, Reported investors

Oct 10, 2017Form D — New notice

Reported sold: $2,000,000 · Target: $15,000,000

Rule 506(b)·2 investors

Mar 7, 2017Form D/A — Amendment

Reported sold: $12,772,362 · Target: $14,500,000

Rule 506(b)·74 investors

Changed: Reported amount sold, Offering target, Reported investors

Jan 6, 2017Form D/A — Amendment

Reported sold: $9,289,149 · Target: $11,275,000

Rule 506(b)·49 investors

Changed: Reported amount sold, Offering target, Reported investors

Sep 18, 2015Form D — New notice

Reported sold: $2,106,922 · Target: $8,200,000

Rule 506(b)·7 investors

Apr 2, 2014Form D — New notice

Reported sold: $668,746 · Target: $5,850,000

Rule 506(b)·8 investors

Apr 16, 2013Form D/A — Amendment

Reported sold: $2,835,003 · Target: $4,000,000

Rule 506·24 investors

Changed: Reported amount sold, Offering target, Reported investors

Nov 21, 2012Form D — New notice

Reported sold: $1,187,000 · Target: $3,600,000

Rule 506·9 investors

Dec 22, 2011Form D/A — Amendment

Reported sold: $2,725,000 · Target: $2,725,000

Rule 506·19 investors

Changed: Reported amount sold, Offering target, Reported investors

Feb 2, 2011Form D — New notice

Reported sold: $100,000 · Target: $2,500,000

Rule 506·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

58%

Latest reported sold across 8 identified offerings

$89,256,021

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

1 unlinked amendment excluded.

Key People

Anne Conner

Director

Appears on 9 filings

John R. Lawson II

Director

Appears on 9 filings

Michael N. Petkovich

Director

Appears on 9 filings

John O. Wynne Jr.

Director

Appears on 9 filings

F. Brian Clare Jr.

Executive Officer, Director

Appears on 9 filings

Erin Wendell

Executive Officer

Appears on 9 filings

Holly Novak

Executive Officer

Appears on 9 filings

Gary P. Warren

Executive Officer, Director

Appears on 9 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 19, 2024	Amendment	$33,283,659	$26,933,659	16
Jun 14, 2024	Amendment	$27,283,659	$22,958,659	16
Jan 26, 2024	New	$20,240,468	$14,390,468	6
Jan 9, 2024	Amendment	$17,452,641	$17,452,641	21
May 4, 2023	New	$14,500,000	$10,692,961	9
Feb 10, 2022	Amendment	$20,000,000	$13,709,845	15
Nov 1, 2021	Amendment	$13,000,000	$10,476,535	14
Jul 7, 2020	New	$13,000,000	$1,500,000	2
Jan 3, 2020	Amendment	$21,000,000	$18,918,445	51
Mar 14, 2019	Amendment	$16,000,000	$12,368,445	47
Oct 10, 2017	New	$15,000,000	$2,000,000	2
Mar 7, 2017	Amendment	$14,500,000	$12,772,362	74
Jan 6, 2017	Amendment	$11,275,000	$9,289,149	49
Sep 18, 2015	New	$8,200,000	$2,106,922	7
Apr 2, 2014	New	$5,850,000	$668,746	8
Apr 16, 2013	Amendment	$4,000,000	$2,835,003	24
Nov 21, 2012	New	$3,600,000	$1,187,000	9
Dec 22, 2011	Amendment	$2,725,000	$2,725,000	19
Feb 2, 2011	New	$2,500,000	$100,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Luminoah, Inc.

Other Health Care

Offering target: $25,413,863

Filed Nov 6, 2026